Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/35855
Title: Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspective
Authors: PONS-ESTEL, Guillermo J.UGARTE-GIL, Manuel FranciscoHARVEY, Guillermina B.WOJDYLA, DanielQUINTANA, RosanaSAURIT, VeronicaSORIANO, Enrique R.BONFA, EloisaMASSARDO, LoretoCARDIEL, MarioVILA, Luis M.GRIFFIN, RussellPONS-ESTEL, Bernardo A.ALARCON, Graciela S.
Citation: RMD OPEN, v.6, n.1, article ID UNSP e001097, 6p, 2020
Abstract: Objective To evaluate the performance of the 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) criteria in terms of earlier patients' classification in comparison to the 1982/1997 ACR or the 2012 Systemic Lupus International Collaborating Clinics (SLICC) criteria. Materials and methods Patients from a Latin America, multiethnic, multicentre cohort, where SLE was defined using the physicians' diagnosis, were included. To calculate the sensitivity of the 2019 EULAR/ACR criteria, the 1982/1997 ACR criteria were considered the gold standard. Additionally, comparison of the 1982/1997 ACR criteria and the 2012 SLICC criteria with the 2019 EULAR/ACR criteria was performed. Results The sensitivity of the 2019 EULAR/ACR criteria when compared with the 1982/1997 ACR criteria as the gold standard was 91.3%. This new set of criteria allowed an earlier SLE patient classification in 7.4% (mean 0.67 years) and 0.6% (mean 1.47 years) than the 1982/1997 ACR and the 2012 SLICC criteria, respectively. Patients accruing the 2019 EULAR/ACR earlier than the 1982/1997 ACR criteria were more likely to have high anti-dsDNA titres; those accruing them later were less likely to have mucocutaneous and joint manifestations; this was not observed when comparing them with the 2012 SLICC criteria. Conclusions The 2019 EULAR/ACR criteria classified earlier only a small proportion of Latin America patients than with the two other criteria sets in real-life clinical practice scenarios. Further studies in different patient populations are needed before these new criteria are adopted worldwide.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/17
LIM/17 - Laboratório de Investigação em Reumatologia


Files in This Item:
File Description SizeFormat 
art_PONS-ESTEL_Applying_the_2019_EULARACR_lupus_criteria_to_patients_2020.PDFpublishedVersion (English)327.87 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.